BioAegis Enrolls First Patient in Global Phase 2b ARDS Study

The massive 600 patient study, to be conducted in 13 countries, will investigate recombinant human plasma gelsolin for Acute Respiratory Distress Syndrome (ARDS). BioAegis is a graduate of the Incubator at North Brunswick and a current resident of the Step-Out Labs at North Brunswick. 

LinusBio Wins 2024 Overall MedTech Company Of The Year !!

The award highlights the company’s precision exposome sequencing technology that analyzes strands of hair to deliver information about a person’s environmental exposures and metabolic reactions. LinusBio, a Mt Sinai spin-off company, is a resident of the Incubator at North Brunswick. 

Zena Therapeutics: Rutgers Spin-Off Designing Safer Prescription Opiates

The goal of Zena Therapeutics is to create narcotic medications that will minimize or even eliminate overdoses from prescription drugs. The Incubator at North Brunswick resident was recently highlighted in ROI-NJ news.

Couragene Awarded $340,000 Phase I NIH STTR Award

Congratulations to Couragene, a genetic medicines company, for their recent STTR Phase 1 award. The Incubator at North Brunswick resident earned the award to help develop an effective treatment for Angelman Syndrome.   

Fidelis Animal Health Announces FDA Label Expansion

Fidelis Animal Health, Inc. has received notification from the FDA that its product, Ethiqa XR, is now indicated for the control of post-procedural pain in captive rodents and laboratory rabbits. Since its launch to laboratory veterinarians in 2020, Ethiqa XR has been used in over five hundred institutions across the country. Fidelis Animal Health is a graduate of the Incubator at North Brunswick and a current resident of the Step-Out Labs.

Skunkworx published in the Journal,“Antibody Therapeutics”

The study demonstrated a rapid antibody discovery approach and identified a novel human TIM-4 antibody that can serve as a therapeutic for antitumor immunity to improve cancer therapy. Skunkworx is a resident of the Incubator at North Brunswick.

New Jersey Bioscience Center Featured at BUILDSBIO+ Symposium

Serving several major international life science cluster communities, including metro NYC, Builds Bio+ events unite participants of regional life science ecosystems. At the BuildsBio+ event hosted at the Times Center in Times Square on November 12^th, NJBC Director, Lenzie Harcum, led a New Jersey focused life science panel. Panel participants included Dr. Susan Levinson, CEO of BioAegis, Dr. John Pena, CEO of Sonder RX and Matt Flath, VP of ONYX Properties, owner of the NEST life science campus in Kenilworth. BioAegis and Sonder are both residents of New Jersey Bioscience Center. 

Link here to watch all seven hours of this exciting program. Or skip to the New Jersey session that spans from 3:54:20 to 4:17:32

Suven Pharma Acquires NJ BIO for $64M

Early in December, Suven Pharmaceuticals acquired a 56% stake in NJ BIO, an Incubator at North Brunswick Graduate. NJBIO is a research services company providing integrated chemistry and biology services. According to the December 7^th issue of THE HINDU, “Suven will buy out existing minority shareholders for $49.4 million besides investing $15 million as primary equity infusion.” NJ Bio Inc. founder Dr. Naresh Jain “will continue as CEO and retain his stake in the company. NJ Bio is expected to record revenues of around $32 million in CY24.”

Acasti Announces Name Change to Grace Therapeutics

As a former Incubator at North Brunswick resident, Grace Therapeutics was the name of the company developing GTx-104 prior to its merger with Acasti in 2021. Grace Therapeutics began trading on NASDAQ under the trading symbol “GRCE” on October 28, 2024. Grace Therapeutics is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. 

NJIT Expanding Into NEST Life Sciences Campus

In mid-December, the NEST announced New Jersey Institute of Technology (NJIT) as its first academic partner at the campus. Read more here

Incubator Chem Labs Available at the New Jersey Bioscience Center

The Incubator at North Brunswick has private chemistry labs available now !! 

Private biology labs are also available.  Email or call New Jersey Bioscience Center Director, Lenzie Harcum (732-839-1880) with any questions or to request a tour of the Incubator at North Brunswick.  

New Jersey Bioscience Center, a 300,000 SF, 50 acre research park that includes the Incubator at North Brunswick, with 27 private wet labs and the multi-tenant Step-Out Labs at North Brunswick for growing biotech companies. Larger life sciences space ranging from 5000 – 32,000 SF.

New Jersey Bioscience Center

675 US Highway One,

North Brunswick, NJ 08902

732-839-1880